17?-<wbr/>hydroxy Wortmannin

17?-hydroxy Wortmannin

CAT N°: 13812
Price:

From 88.00 74.80

17?-hydroxy Wortmannin is an analog of wortmannin. It irreversibly binds phosphoinositide 3-kinase (PI3K) and potently blocks fMLP-stimulated respiratory burst in neutrophils (IC50 = 5 nM).{18125} 17?-hydroxy Wortmannin inhibits recombinant PI3K and mTOR (IC50 = 2.7 and 193 nM, respectively) and prevents the growth of LNCap prostate cancer cells (IC50 = 1.46 ?M).{18123} The 17-hydroxyl group has been used to further modify this compound, e.g., by pegylation and conjugation with rapamycin.{18124,17899}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 17?-hydroxy-11-(acetyloxy)-1S,6bR,7,8,9aS,10,11R,11bR-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-3H-furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione
  • Correlated keywords
    • phosphoinositide 3-kinase PI3K mTOR inhibitors inhibits inhibition inhibitory cancers 17-hydroxywortmannins 17-hydroxy wortmannins hydroxywortmannins PI3-K HWT phosphatidylinositol
  • Product Overview:
    17?-hydroxy Wortmannin is an analog of wortmannin. It irreversibly binds phosphoinositide 3-kinase (PI3K) and potently blocks fMLP-stimulated respiratory burst in neutrophils (IC50 = 5 nM).{18125} 17?-hydroxy Wortmannin inhibits recombinant PI3K and mTOR (IC50 = 2.7 and 193 nM, respectively) and prevents the growth of LNCap prostate cancer cells (IC50 = 1.46 ?M).{18123} The 17-hydroxyl group has been used to further modify this compound, e.g., by pegylation and conjugation with rapamycin.{18124,17899}

We also advise you